Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 153

1.

Evaluation of the predictive value of the bleeding prediction score VTE-BLEED for recurrent venous thromboembolism.

Klok FA, Presles E, Tromeur C, Barco S, Konstantinides SV, Sanchez O, Pernod G, Raj L, Robin P, Le Roux PY, Hoffman C, Mélac S, Bertoletti L, Girard P, Laporte S, Mismetti P, Meyer G, Leroyer C, Couturaud F; PADIS‐PE Investigators.

Res Pract Thromb Haemost. 2019 May 25;3(3):364-371. doi: 10.1002/rth2.12214. eCollection 2019 Jul.

2.

[Recommendations for best practice in the management of venous thromboembolic disease in adults. Long version].

Sanchez O, Benhamou Y, Bertoletti L, Constans J, Couturaud F, Delluc A, Elias A, Fischer AM, Frappé P, Gendron N, Girard P, Godier A, Gut-Gobert C, Laporte S, Mahé I, Mauge L, Meneveau N, Meyer G, Mismetti P, Parent F, Pernod G, Quéré I, Revel MP, Roy PM, Salaün PY, Smadja DM, Sevestre MA.

Rev Mal Respir. 2019 Jul 4. pii: S0761-8425(19)30210-4. doi: 10.1016/j.rmr.2019.05.038. [Epub ahead of print] French. No abstract available.

PMID:
31280989
3.

Predictors for Residual Pulmonary Vascular Obstruction after Unprovoked Pulmonary Embolism: Implications for Clinical Practice-The PADIS-PE Trial.

Raj L, Robin P, Le Mao R, Presles E, Tromeur C, Sanchez O, Pernod G, Bertoletti L, Jego P, Leven F, Lemarié CA, Martin A, Planquette B, Le Roux PY, Salaun PY, Nonent M, Girard P, Lacut K, Melac S, Mismetti P, Laporte S, Meyer G, Leroyer C, Couturaud F; PADIS-PE Investigators.

Thromb Haemost. 2019 Jun 23. doi: 10.1055/s-0039-1692424. [Epub ahead of print]

PMID:
31230343
4.

Erratum à « Unresolved questions on venous thromboembolic disease. Consensus statement of the French Society for Vascular Medicine (SFMV) » [J. Med. Vasc. 44 (2019) 28–70].

Quéré I, Elias A, Maufus M, Elias M, Sevestre MA, Galanaud JP, Bosson JL, Bura-Rivière A, Jurus C, Lacroix P, Zuily S, Diard A, Wahl D, Bertoletti L, Brisot D, Frappe P, Gillet JL, Ouvry P, Pernod G.

J Med Vasc. 2019 Jun;44(4):307-308. doi: 10.1016/j.jdmv.2019.04.009. Epub 2019 May 15. French. No abstract available.

PMID:
31213305
5.

Endovascular Treatment of Post-thrombotic Venous Ilio-Femoral Occlusions: Prognostic Value of Venous Lesions Caudal to the Common Femoral Vein.

Menez C, Rodiere M, Ghelfi J, Seinturier C, Martinelli T, Imbert B, Perolat R, Bouzat P, Blaise S, Carpentier P, Pernod G, Thony F.

Cardiovasc Intervent Radiol. 2019 Aug;42(8):1117-1127. doi: 10.1007/s00270-019-02214-9. Epub 2019 May 6.

PMID:
31062068
6.

Apixaban for the prevention of thromboembolism in immunomodulatory-treated myeloma patients: Myelaxat, a phase 2 pilot study.

Pegourie B, Karlin L, Benboubker L, Orsini-Piocelle F, Tiab M, Auger-Quittet S, Rodon P, Royer B, Leleu X, Bareau B, Cliquennois M, Fuzibet JG, Voog E, Belhadj-Merzoug K, Decaux O, Rey P, Slama B, Leyronnas C, Zarnitsky C, Boyle E, Bosson JL, Pernod G; IFM Group.

Am J Hematol. 2019 Jun;94(6):635-640. doi: 10.1002/ajh.25459. Epub 2019 Apr 1.

PMID:
30859608
7.

[Recommendations of good practice for the management of thromboembolic venous disease in adults. Short version].

Sanchez O, Benhamou Y, Bertoletti L, Constant J, Couturaud F, Delluc A, Elias A, Fischer AM, Frappé P, Gendron N, Girard P, Godier A, Gut-Gobert C, Laporte S, Mahé I, Mauge L, Meneveau N, Meyer G, Mismetti P, Parent F, Pernod G, Quéré I, Revel MP, Roy PM, Salaün PY, Smadja DM, Sevestre MA.

Rev Mal Respir. 2019 Feb;36(2):249-283. doi: 10.1016/j.rmr.2019.01.003. Epub 2019 Feb 22. French. No abstract available.

PMID:
30799126
8.

[Unresolved questions on venous thromboembolic disease. Consensus statement of the French Society for Vascular Medicine (SFMV)].

Quéré I, Elias A, Maufus M, Elias M, Sevestre MA, Galanaud JP, Bosson JL, Bura-Rivière A, Jurus C, Lacroix P, Zuily S, Diard A, Wahl D, Bertoletti L, Brisot D, Frappe P, Gillet JL, Ouvry P, Pernod G.

J Med Vasc. 2019 Feb;44(1):e1-e47. doi: 10.1016/j.jdmv.2018.12.178. Epub 2019 Feb 2. French. No abstract available.

PMID:
30770089
9.

Unresolved questions on venous thromboembolic disease. Consensus statement of the French Society for Vascular Medicine (SFMV).

Quéré I, Elias A, Maufus M, Elias M, Sevestre MA, Galanaud JP, Bosson JL, Bura-Rivière A, Jurus C, Lacroix P, Zuily S, Diard A, Wahl D, Bertoletti L, Brisot D, Frappe P, Gillet JL, Ouvry P, Pernod G.

J Med Vasc. 2019 Feb;44(1):28-70. doi: 10.1016/j.jdmv.2018.12.003. Epub 2019 Jan 23. No abstract available. Erratum in: J Med Vasc. 2019 Jun;44(4):307-308.

PMID:
30770082
10.

Six months versus two years of oral anticoagulation after a first episode of unprovoked deep-vein thrombosis. The PADIS-DVT randomized clinical trial.

Couturaud F, Pernod G, Presles E, Duhamel E, Jego P, Provost K, Pan-Petesch B, Sollier CBD, Tromeur C, Hoffmann C, Bressollette L, Lorillon P, Girard P, Le Moigne E, Le Hir A, Guégan M, Laporte S, Mismetti P, Lacut K, Bosson JL, Bertoletti L, Sanchez O, Meyer G, Leroyer C, Mottier D; “PADIS-DVT” investigators.

Haematologica. 2019 Jul;104(7):1493-1501. doi: 10.3324/haematol.2018.210971. Epub 2019 Jan 3.

11.

HIBISCUS: Hydroxychloroquine for the secondary prevention of thrombotic and obstetrical events in primary antiphospholipid syndrome.

Belizna C, Pregnolato F, Abad S, Alijotas-Reig J, Amital H, Amoura Z, Andreoli L, Andres E, Aouba A, Apras Bilgen S, Arnaud L, Bienvenu B, Bitsadze V, Blanco P, Blank M, Borghi MO, Caligaro A, Candrea E, Canti V, Chiche L, Chretien JM, Cohen Tervaert JW, Damian L, Delross T, Dernis E, Devreese K, Djokovic A, Esteve-Valverde E, Favaro M, Fassot C, Ferrer-Oliveras R, Godon A, Hamidou M, Hasan M, Henrion D, Imbert B, Jeandel PY, Jeannin P, Jego P, Jourde-Chiche N, Khizroeva J, Lambotte O, Landron C, Latino JO, Lazaro E, de Leeuw K, Le Gallou T, Kiliç L, Limper M, Loufrani L, Lubin R, Magy-Bertrand N, Mahe G, Makatsariya A, Martin T, Muchardt C, Nagy G, Omarjee L, Van Paasen P, Pernod G, Perrinet F, Pïres Rosa G, Pistorius MA, Ruffatti A, Said F, Saulnier P, Sene D, Sentilhes L, Shovman O, Sibilia J, Sinescu C, Stanisavljevic N, Stojanovich L, Tam LS, Tincani A, Tollis F, Udry S, Ungeheuer MN, Versini M, Cervera R, Meroni PL.

Autoimmun Rev. 2018 Dec;17(12):1153-1168. doi: 10.1016/j.autrev.2018.05.012. Epub 2018 Oct 12. Review.

PMID:
30316994
12.

Validation of the STA-Liatest DDi assay for exclusion of proximal deep vein thrombosis according to the latest Clinical and Laboratory Standards Institute/Food and Drug Administration guideline: results of a multicenter management study.

Aguilar C, Sartori M, D'Angelo A, Kabrhel C, Groce J, de Maistre E, Wasan SM, Kassis J, Lazarchick J, Kaide C, Vera PM, Kline J, Courtney DM, Rubin A, Sharafuddin M, Pernod G; DiET Study Group.

Blood Coagul Fibrinolysis. 2018 Sep;29(6):562-566. doi: 10.1097/MBC.0000000000000750.

13.

[College of the French Vascular Medicine Teachers (CEMV) statement: Arterial Doppler waveforms analysis (simplified Saint-Bonnet classification)].

Mahé G, Boulon C, Désormais I, Lacroix P, Bressollette L, Guilmot JL, Le Hello C, Sevestre MA, Pernod G, Constans J, Boissier C, Bura-Rivière A; Collège des enseignants de médecine vasculaire (CEMV).

J Med Vasc. 2018 Jul;43(4):255-261. doi: 10.1016/j.jdmv.2018.05.002. Epub 2018 Jun 20. French.

14.

Long-term outcomes of isolated superficial vein thrombosis in patients with active cancer.

Galanaud JP, Blaise S, Sevestre MA, Terrisse H, Pernod G, Gaillard C, Genty C, Monreal M, Rabah Y, Kahn SR, Quéré I, Bosson JL; OPTIMEV-SFMV investigators.

Thromb Res. 2018 Nov;171:179-186. doi: 10.1016/j.thromres.2018.04.013. Epub 2018 Apr 20.

PMID:
29789147
15.

Management of bleeding and emergency invasive procedures in patients on dabigatran: Updated guidelines from the French Working Group on Perioperative Haemostasis (GIHP) - September 2016.

Albaladejo P, Pernod G, Godier A, de Maistre E, Rosencher N, Mas JL, Fontana P, Samama CM, Steib A, Schlumberger S, Marret E, Roullet S, Susen S, Madi-Jebara S, Nguyen P, Schved JF, Bonhomme F, Sié P; members of the French Working Group on Perioperative Haemostasis.

Anaesth Crit Care Pain Med. 2018 Aug;37(4):391-399. doi: 10.1016/j.accpm.2018.04.009. Epub 2018 May 2. Review.

16.

Anemia and bleeding in patients receiving anticoagulant therapy for venous thromboembolism: comment.

Gaboreau Y, Zenatti N, Vermorel C, Imbert P, Bosson JL, Pernod G.

J Thromb Thrombolysis. 2018 Jul;46(1):84-87. doi: 10.1007/s11239-018-1668-4.

PMID:
29687300
17.

Risk factors for recurrent venous thromboembolism after unprovoked pulmonary embolism: the PADIS-PE randomised trial.

Tromeur C, Sanchez O, Presles E, Pernod G, Bertoletti L, Jego P, Duhamel E, Provost K, Parent F, Robin P, Deloire L, Leven F, Mingant F, Bressollette L, Le Roux PY, Salaun PY, Nonent M, Pan-Petesch B, Planquette B, Girard P, Lacut K, Melac S, Mismetti P, Laporte S, Meyer G, Mottier D, Leroyer C, Couturaud F; PADIS-PE Investigators18.

Eur Respir J. 2018 Jan 4;51(1). pii: 1701202. doi: 10.1183/13993003.01202-2017. Print 2018 Jan.

18.

Diagnosis of deep vein thrombosis recurrence: Ultrasound criteria.

Maufus M, Elias A, Barrellier MT, Pernod G; French Society for Vascular Medicine.

Thromb Res. 2018 Jan;161:78-83. doi: 10.1016/j.thromres.2017.11.004. Epub 2017 Nov 14. Review.

PMID:
29216479
19.

Prevention and treatment of cancer-associated thrombosis in France: A national survey among vascular disease and supportive care specialists.

Mahé I, Scotté F, Rey JB, Elalamy I, Lamblin A, Mayeur D, Pernod G; AFSOS (French-speaking Association for Supportive Care in Oncology), SFMV (French Society for Vascular Medicine).

J Med Vasc. 2017 Oct;42(5):255-262. doi: 10.1016/j.jdmv.2017.07.002. Epub 2017 Sep 4.

PMID:
28964384
20.

Prevalence and severity of peripheral arterial disease among patient with heel pressure ulcer: a retrospective study of 42 patients.

Tisserand G, Zenati N, Seinturier C, Blaise S, Pernod G.

Geriatr Psychol Neuropsychiatr Vieil. 2017 Sep 1;15(3):242-246. doi: 10.1684/pnv.2017.0680.

PMID:
28872035
21.

Impact of an educational program on the quality of life of patients with lymphedema: A preliminary evaluation.

Blaise S, Satger B, Pernod G, Richaud C, Villemur B, Carpentier PH.

J Vasc Surg Venous Lymphat Disord. 2017 Sep;5(5):715-722.e1. doi: 10.1016/j.jvsv.2017.06.004.

PMID:
28818227
22.

Is contrast enhanced ultrasonography a useful tool for the evaluation of muscular microcirculation in patients with critical limb ischaemia?

Seinturier C, Blaise S, Pichot O, Guigard S, Genty C, Jean Luc M, Jean Luc B, Pernod G, Carpentier PH.

Vasa. 2017 Aug;46(5):389-394. doi: 10.1024/0301-1526/a000645. Epub 2017 Jun 30.

23.

Autologous Bone Marrow Mononuclear Cell Implantation and Its Impact on the Outcome of Patients With Critical Limb Ischemia - Results of a Randomized, Double-Blind, Placebo-Controlled Trial.

Pignon B, Sevestre MA, Kanagaratnam L, Pernod G, Stephan D, Emmerich J, Clement C, Sarlon G, Boulon C, Tournois C, Nguyen P.

Circ J. 2017 Oct 25;81(11):1713-1720. doi: 10.1253/circj.CJ-17-0045. Epub 2017 Jun 10.

24.

Statement for Doppler waveforms analysis.

Mahé G, Boulon C, Desormais I, Lacroix P, Bressollette L, Guilmot JL, Le Hello C, Sevestre MA, Pernod G, Constans J, Boissier C, Bura-Rivière A.

Vasa. 2017 Aug;46(5):337-345. doi: 10.1024/0301-1526/a000638. Epub 2017 May 19. Review.

25.

Management of Severe Bleeding in Patients Treated with Direct Oral Anticoagulants: An Observational Registry Analysis.

Albaladejo P, Samama CM, Sié P, Kauffmann S, Mémier V, Suchon P, Viallon A, David JS, Gruel Y, Bellamy L, de Maistre E, Romegoux P, Thoret S, Pernod G, Bosson JL; GIHP-NACO Study Group.

Anesthesiology. 2017 Jul;127(1):111-120. doi: 10.1097/ALN.0000000000001631.

PMID:
28410272
26.

Long-term risk of venous thromboembolism recurrence after isolated superficial vein thrombosis.

Galanaud JP, Sevestre MA, Pernod G, Kahn SR, Genty C, Terrisse H, Brisot D, Gillet JL, Quéré I, Bosson JL.

J Thromb Haemost. 2017 Jun;15(6):1123-1131. doi: 10.1111/jth.13679. Epub 2017 May 5.

27.

Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study.

Rodger MA, Le Gal G, Anderson DR, Schmidt J, Pernod G, Kahn SR, Righini M, Mismetti P, Kearon C, Meyer G, Elias A, Ramsay T, Ortel TL, Huisman MV, Kovacs MJ; REVERSE II Study Investigators.

BMJ. 2017 Mar 17;356:j1065. doi: 10.1136/bmj.j1065.

28.

Long-term outcomes of cancer-related isolated distal deep vein thrombosis: the OPTIMEV study.

Galanaud JP, Sevestre MA, Pernod G, Genty C, Richelet S, Kahn SR, Boulon C, Terrisse H, Quéré I, Bosson JL.

J Thromb Haemost. 2017 May;15(5):907-916. doi: 10.1111/jth.13664. Epub 2017 Apr 21.

29.

Early antithrombotic treatment with warfarin oral suspension in severe neonatal protein C deficiency.

Milleret C, Epiard C, Douchin S, Pernod G, Debillon T.

Arch Pediatr. 2017 Apr;24(4):363-366. doi: 10.1016/j.arcped.2017.01.007. Epub 2017 Mar 1.

PMID:
28259509
30.

A Femoral Common Vein Aneurysm in a Patient with Neurofibromatosis Syndrome Type 1.

Seinturier C, Blaise S, Thony F, Magne JL, Pernod G.

Ann Vasc Surg. 2017 Apr;40:299.e7-299.e9. doi: 10.1016/j.avsg.2016.08.039. Epub 2017 Feb 3.

PMID:
28163183
31.

Anaemia as an independent key risk factor for major haemorrhage in patients treated with vitamin K antagonists: Results of the SCORE prospective cohort.

Zenati N, Gaboreau Y, Provencher CB, Albaladejo P, Bosson JL, Pernod G.

Thromb Res. 2017 Mar;151:83-88. doi: 10.1016/j.thromres.2016.10.027. Epub 2016 Oct 28.

PMID:
28109541
32.

D-Dimer Use and Pulmonary Embolism Diagnosis in Emergency Units: Why Is There Such a Difference in Pulmonary Embolism Prevalence between the United States of America and Countries Outside USA?

Pernod G, Caterino J, Maignan M, Tissier C, Kassis J, Lazarchick J; DIET study group.

PLoS One. 2017 Jan 13;12(1):e0169268. doi: 10.1371/journal.pone.0169268. eCollection 2017.

33.

Critical limb ischaemia and the response to bone marrow-derived cell therapy according to tcPO2 measurement.

Maufus M, Sevestre-Pietri MA, Sessa C, Pignon B, Egelhofer H, Dupas S, Nguyen P, Genty C, Pernod G.

Vasa. 2017 Jan;46(1):23-28. doi: 10.1024/0301-1526/a000590. Epub 2016 Nov 21.

34.

Questioning the use of an age-adjusted D-dimer threshold to exclude venous thromboembolism: analysis of individual patient data from two diagnostic studies: comment.

Pernod G, Maignan M, Marlu R.

J Thromb Haemost. 2016 Dec;14(12):2553-2554. doi: 10.1111/jth.13472. Epub 2016 Oct 24. No abstract available.

35.

Validation of STA-Liatest D-Di assay for exclusion of pulmonary embolism according to the latest Clinical and Laboratory Standard Institute/Food and Drug Administration guideline. Results of a multicenter management study.

Pernod G, Wu H, de Maistre E, Lazarchick J, Kassis J, Aguilar C, Vera PM, Palareti G, D'Angelo A; DiET Study Group (Jeffrey Caterino, Fabienne Dutrillaux, Gary Headden, Colin Kaide, Maxime Maignan, Raphaël Marlu, Anais Richard, Cindy Tissier).

Blood Coagul Fibrinolysis. 2017 Apr;28(3):254-260. doi: 10.1097/MBC.0000000000000591.

36.

Low incidence of cancer after venous thromboembolism: An update from the French OPTIMEV Cohort.

Arnoult AC, Pernod G, Genty C, Galanaud JP, Colonna M, Sevestre MA, Bosson JL.

J Mal Vasc. 2016 May;41(3):169-75. doi: 10.1016/j.jmv.2016.03.001. Epub 2016 Apr 11.

PMID:
27080824
37.

[Comparison of the HAS-BLED and ATRIA scores for the risk of bleeding in patients aged 75 and over receiving vitamin K antagonist (VKA) therapy and educated VKA-management].

Soave C, Chidlovskii E, Lebelhomme A, Gaboreau Y, Pernod G, Bosson JL, Couturier P.

Geriatr Psychol Neuropsychiatr Vieil. 2015 Sep;13(3):279-88. doi: 10.1684/pnv.2015.0562. French.

PMID:
26395301
38.

[Management of deep-vein thrombosis: A 2015 update].

Messas E, Wahl D, Pernod G; Collège des Enseignants de Médecine Vasculaire.

J Mal Vasc. 2016 Feb;41(1):42-50. doi: 10.1016/j.jmv.2015.07.105. Epub 2015 Sep 8. Review. French.

PMID:
26357937
39.

Is it useful to also image the asymptomatic leg in patients with suspected deep vein thrombosis?: comment.

Galanaud JP, Sevestre MA, Genty C, Pernod G, Quere I, Bosson JL.

J Thromb Haemost. 2015 Nov;13(11):2127-30. doi: 10.1111/jth.13123. Epub 2015 Sep 30. No abstract available.

40.

[Management of pulmonary embolism: A 2015 update].

Galanaud JP, Blanchet-Deverly A, Pernod G, Quéré I; Pour le Collège des Enseignants de Médecine Vasculaire.

J Mal Vasc. 2016 Feb;41(1):51-62. doi: 10.1016/j.jmv.2015.07.003. Epub 2015 Aug 14. Review. French.

PMID:
26283060
41.

[Management of venous thromboembolism: A 2015 update].

Galanaud JP, Messas E, Blanchet-Deverly A, Quéré I, Wahl D, Pernod G; College of Vascular Medicine Teachers (CEMV).

Rev Med Interne. 2015 Nov;36(11):746-52. doi: 10.1016/j.revmed.2015.06.004. Epub 2015 Jul 30. Review. French.

PMID:
26235049
42.

Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism: The PADIS-PE Randomized Clinical Trial.

Couturaud F, Sanchez O, Pernod G, Mismetti P, Jego P, Duhamel E, Provost K, dit Sollier CB, Presles E, Castellant P, Parent F, Salaun PY, Bressollette L, Nonent M, Lorillon P, Girard P, Lacut K, Guégan M, Bosson JL, Laporte S, Leroyer C, Décousus H, Meyer G, Mottier D; PADIS-PE Investigators.

JAMA. 2015 Jul 7;314(1):31-40. doi: 10.1001/jama.2015.7046.

PMID:
26151264
43.

[Etiologic assessment of venous thromboembolism].

Pernod G.

Rev Prat. 2015 Feb;65(2):182-7. French.

PMID:
25939218
44.

Long-term therapy with bevacizumab in a patient with Glanzmann's thrombasthenia and recurrent digestive bleeding due to gastrointestinal angiodysplastic lesions.

Marlu R, Barthelon J, Durand A, Mathieu N, Barro C, Granger V, Tatu A, Pernod G, Polack B, Bonaz B.

Am J Gastroenterol. 2015 Feb;110(2):352-3. doi: 10.1038/ajg.2014.391. No abstract available.

PMID:
25646919
45.

Ex vivo reversal of the anticoagulant effects of edoxaban - comments on the study by Halim et al.

Marlu R, Polack B, Pernod G.

Thromb Res. 2015 Mar;135(3):571. doi: 10.1016/j.thromres.2015.01.002. Epub 2015 Jan 7. No abstract available.

PMID:
25628140
46.

Antithrombotic therapy after infrainguinal bypass.

Maufus M, Pernod G.

J Vasc Surg. 2014 Nov;60(5):1367-1375. doi: 10.1016/j.jvs.2014.07.105. Epub 2014 Oct 23. Review.

47.

Letter by Chaix et al regarding article, "Impact of incident venous thromboembolism on risk of arterial thrombotic diseases".

Chaix M, Bosson JL, Pernod G.

Circulation. 2014 Nov 18;130(21):e183. doi: 10.1161/CIRCULATIONAHA.114.008845. No abstract available.

PMID:
25403601
48.

Recanalization and stenting of a post-thrombotic iliac vein in a patient with Behçet's disease.

Seinturier C, Thony F, Blaise S, Pernod G, Carpentier PH.

J Vasc Surg Venous Lymphat Disord. 2014 Jul;2(3):324-6. doi: 10.1016/j.jvsv.2013.11.002. Epub 2014 Jan 15.

PMID:
26993393
50.

[Perioperative management of new oral anticoagulants].

Samama CM, Pernod G, Albaladejo P, Sie P; Groupe d’intérêt en hémostase péri-opératoire (GIHP).

Presse Med. 2014 Jun;43(6 Pt 1):637-44. doi: 10.1016/j.lpm.2013.11.025. Epub 2014 Apr 16. Review. French.

PMID:
24742616

Supplemental Content

Loading ...
Support Center